Bionime Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Roy Huang
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 22.2yrs |
CEO ownership | n/a |
Management average tenure | 5.8yrs |
Board average tenure | 2.2yrs |
Recent management updates
Recent updates
These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong
Apr 29Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?
Mar 23Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?
Mar 05Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?
Feb 15Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet
Feb 01How Has Bionime (TPE:4737) Allocated Its Capital?
Jan 19A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE
Jan 06A Look At The Fair Value Of Bionime Corporation (TPE:4737)
Dec 22Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend
Dec 09Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment
Nov 24CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | NT$6m |
Sep 30 2023 | n/a | n/a | NT$22m |
Jun 30 2023 | n/a | n/a | NT$43m |
Mar 31 2023 | n/a | n/a | NT$72m |
Dec 31 2022 | n/a | n/a | NT$91m |
Sep 30 2022 | n/a | n/a | NT$95m |
Jun 30 2022 | n/a | n/a | NT$115m |
Mar 31 2022 | n/a | n/a | NT$89m |
Dec 31 2021 | NT$4m | NT$4m | NT$87m |
Sep 30 2021 | n/a | n/a | NT$101m |
Jun 30 2021 | n/a | n/a | NT$111m |
Mar 31 2021 | n/a | n/a | NT$83m |
Dec 31 2020 | NT$4m | NT$4m | NT$62m |
Sep 30 2020 | n/a | n/a | NT$73m |
Jun 30 2020 | n/a | n/a | NT$38m |
Mar 31 2020 | n/a | n/a | NT$91m |
Dec 31 2019 | NT$5m | NT$4m | NT$106m |
Compensation vs Market: Insufficient data to establish whether Roy's total compensation is reasonable compared to companies of similar size in the TW market.
Compensation vs Earnings: Roy's compensation has been consistent with company performance over the past year.
CEO
Roy Huang
22.2yrs
Tenure
NT$4,429,000
Compensation
Mr. Chun-Mu Huang also known as Roy, founded Bionime Corporation in 2002. Mr. Huang serves as Chairman and General Manager of Bionime Corporation and has been its Director since April 14, 2003. He Complete...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 22.2yrs | NT$4.43m | no data | |
CFO, Assistant GM of Administration Division & Corporate Governance Officer | 6.3yrs | no data | no data | |
Assistant General Manager of Operation Division | 8.1yrs | no data | no data | |
Accounting Officer | 3.1yrs | no data | no data | |
Vice President of Research and Development | no data | no data | no data | |
Assistant General Manager of Sales Division | 5.3yrs | no data | no data | |
Assistant General Manager of Marketing Planning Division | 5.3yrs | no data | no data |
5.8yrs
Average Tenure
Experienced Management: 4737's management team is seasoned and experienced (5.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 20.9yrs | NT$4.43m | no data | |
Representative Director | 4.8yrs | NT$533.00k | no data | |
Representative Director | 2.1yrs | no data | no data | |
Independent Director | no data | no data | no data | |
Independent Director | no data | no data | no data | |
Independent Director | no data | no data | no data | |
Director | 2.2yrs | no data | no data | |
Additional Independent Director | less than a year | no data | no data |
2.2yrs
Average Tenure
Experienced Board: 4737's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.